Paradoxical and contradictory effects of imatinib in two cell line models of hormone-refractory prostate cancer
Author:
Affiliation:
1. CICS-UBI; Health Sciences Research Center; University of Beira Interior; Covilhã Portugal
Funder
Portuguese Foundation for Science and Technology
Publisher
Wiley
Subject
Urology,Oncology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/pros.22976/fullpdf
Reference93 articles.
1. Cancer statistics, 2014;Siegel;CA Cancer J Clin,2014
2. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012;Ferlay;Eur J Cancer,2012
3. Androgens and prostate cancer; pathogenesis and deprivation therapy;Grossmann;Best Pract Res Clin Endocrinol Metab,2013
4. Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches;Karantanos;Oncogene,2013
5. Androgen receptor as a driver of therapeutic resistance in advanced prostate cancer;Kahn;Int J Biol Sci,2014
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Resistance of prostate cancer to kinase inhibitors;Therapy Resistance in Prostate Cancer;2024
2. Role and Significance of c-KIT Receptor Tyrosine Kinase in Cancer: A Review;Bosnian Journal of Basic Medical Sciences;2022-04-27
3. Imatinib mesylate inhibits androgen-independent PC-3 cell viability, proliferation, migration, and tumor growth by targeting platelet-derived growth factor receptor-α;Life Sciences;2022-01
4. Effect of l-carnitine on cardiotoxicity and apoptosis induced by imatinib through PDGF/ PPARγ /MAPK pathways;Archives of Biochemistry and Biophysics;2021-06
5. Targeting MDR‐1 gene expression, BAX/BCL2, caspase‐3, and Ki‐67 by nanoencapsulated imatinib and hesperidin to enhance anticancer activity and ameliorate cardiotoxicity;Fundamental & Clinical Pharmacology;2020-03-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3